{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:13:58Z","timestamp":1783437238301,"version":"3.54.6"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Ratchadapiseksumpotch Fund for Graduate Affairs"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1038\/s41433-026-04462-9","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:49:45Z","timestamp":1777942185000},"page":"1461-1468","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Agreements between 24-2 and 24-2\u2009C test grids for chloroquine\/hydroxychloroquine retinopathy patients and high-risk patients"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-0410-7807","authenticated-orcid":false,"given":"Chananchida","family":"Wongwachira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Disorn","family":"Suwajanakorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wijak","family":"Kongwattananon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunee","family":"Chansangpetch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Manassakorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pear Ferreira","family":"Pongsachareonnont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rath","family":"Itthipanichpong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Visanee","family":"Tantisevi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prin","family":"Rojanapongpun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4743-5189","authenticated-orcid":false,"given":"Kitiya","family":"Ratanawongphaibul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"key":"4462_CR1","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/eye.2016.298","volume":"31","author":"IH Yusuf","year":"2017","unstructured":"Yusuf IH, Sharma S, Luqmani R, Downes SM. Hydroxychloroquine retinopathy. Eye (Lond). 2017;31:828\u201345.","journal-title":"Eye (Lond)"},{"key":"4462_CR2","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1001\/jamaophthalmol.2014.3459","volume":"132","author":"RB Melles","year":"2014","unstructured":"Melles RB, Marmor MF. The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy. JAMA Ophthalmol. 2014;132:1453\u201360.","journal-title":"JAMA Ophthalmol"},{"key":"4462_CR3","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.ophtha.2016.01.058","volume":"123","author":"MF Marmor","year":"2016","unstructured":"Marmor MF, Kellner U, Lai TY, Melles RB, Mieler WF. American Academy of O. recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision). Ophthalmology. 2016;123:1386\u201394.","journal-title":"Ophthalmology"},{"key":"4462_CR4","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1038\/s41433-020-01380-2","volume":"35","author":"IH Yusuf","year":"2021","unstructured":"Yusuf IH, Foot B, Lotery AJ. The Royal College of Ophthalmologists recommendations on monitoring for hydroxychloroquine and chloroquine users in the United Kingdom (2020 revision): executive summary. Eye (Lond). 2021;35:1532\u20137.","journal-title":"Eye (Lond)"},{"key":"4462_CR5","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ophtha.2014.07.018","volume":"122","author":"RB Melles","year":"2015","unstructured":"Melles RB, Marmor MF. Pericentral retinopathy and racial differences in hydroxychloroquine toxicity. Ophthalmology. 2015;122:110\u20136.","journal-title":"Ophthalmology"},{"key":"4462_CR6","first-page":"66","volume":"33","author":"NHP Vilainerun","year":"2019","unstructured":"Vilainerun NHP. Patterns of hydroxychloroquine and chloroquine retinopathy in Thai patients. Thai J Ophthalmol. 2019;33:66\u201375.","journal-title":"Thai J Ophthalmol"},{"key":"4462_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1167\/tvst.5.2.15","volume":"5","author":"LM Grillo","year":"2016","unstructured":"Grillo LM, Wang DL, Ramachandran R, Ehrlich AC, De Moraes CG, Ritch R, et al. The 24-2 visual field test misses central macular damage confirmed by the 10-2 visual field test and optical coherence tomography. Transl Vis Sci Technol. 2016;5:15.","journal-title":"Transl Vis Sci Technol"},{"key":"4462_CR8","doi-asserted-by":"publisher","first-page":"e285","DOI":"10.1097\/IJG.0000000000001844","volume":"30","author":"T Chakravarti","year":"2021","unstructured":"Chakravarti T, Moghadam M, Proudfoot JA, Weinreb RN, Bowd C, Zangwill LM. Agreement between 10-2 and 24-2C visual field test protocols for detecting glaucomatous central visual field defects. J Glaucoma. 2021;30:e285\u2013e91.","journal-title":"J Glaucoma"},{"key":"4462_CR9","doi-asserted-by":"publisher","first-page":"e606","DOI":"10.1097\/WNO.0000000000001157","volume":"41","author":"MLM Yamane","year":"2021","unstructured":"Yamane MLM, Odel JG. Introducing the 24-2C visual field test in neuro-ophthalmology. J Neuroophthalmol. 2021;41:e606\u2013e11.","journal-title":"J Neuroophthalmol"},{"key":"4462_CR10","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1001\/archophthalmol.2011.371","volume":"130","author":"MF Marmor","year":"2012","unstructured":"Marmor MF. Comparison of screening procedures in hydroxychloroquine toxicity. Arch Ophthalmol. 2012;130:461\u20139.","journal-title":"Arch Ophthalmol"},{"key":"4462_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10633-014-9474-6","volume":"130","author":"VC Greenstein","year":"2015","unstructured":"Greenstein VC, Amaro-Quireza L, Abraham ES, Ramachandran R, Tsang SH, Hood DC. A comparison of structural and functional changes in patients screened for hydroxychloroquine retinopathy. Doc Ophthalmol. 2015;130:13\u201323.","journal-title":"Doc Ophthalmol"},{"key":"4462_CR12","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.ajo.2020.06.024","volume":"219","author":"J Phu","year":"2020","unstructured":"Phu J, Kalloniatis M. Ability of 24-2C and 24-2 grids to identify central visual field defects and structure-function concordance in glaucoma and suspects. Am J Ophthalmol. 2020;219:317\u201331.","journal-title":"Am J Ophthalmol"},{"key":"4462_CR13","first-page":"1267","volume":"63","author":"S Su","year":"2022","unstructured":"Su S, Callan T, Yu S, Graves N, Wu C, Falkenstein IA, et al. Comparison of 24-2C SITA standard and 24-2C SITA faster. Investig Ophthalmol Vis Sci. 2022;63:1267\u2013A0407. -1267 \u2013 A0407.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"4462_CR14","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ogla.2022.08.006","volume":"6","author":"VP Costa","year":"2023","unstructured":"Costa VP, Zangalli CS, Jammal AA, Medeiros FA, Miyazaki J, Perez V, et al. 24-2 SITA standard versus 24-2 SITA faster in perimetry-naive normal subjects. Ophthalmol Glaucoma. 2023;6:129\u201336.","journal-title":"Ophthalmol Glaucoma"},{"key":"4462_CR15","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ajo.2018.10.010","volume":"198","author":"A Heijl","year":"2019","unstructured":"Heijl A, Patella VM, Chong LX, Iwase A, Leung CK, Tuulonen A, et al. A new SITA perimetric threshold testing algorithm: construction and a multicenter clinical study. Am J Ophthalmol. 2019;198:154\u201365.","journal-title":"Am J Ophthalmol"},{"key":"4462_CR16","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","volume":"1","author":"JM Bland","year":"1986","unstructured":"Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307\u201310.","journal-title":"Lancet"},{"key":"4462_CR17","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.ogla.2020.12.001","volume":"4","author":"EY Choi","year":"2021","unstructured":"Choi EY, Li D, Fan Y, Pasquale LR, Shen LQ, Boland MV, et al. Predicting global test-retest variability of visual fields in glaucoma. Ophthalmol Glaucoma. 2021;4:390\u20139.","journal-title":"Ophthalmol Glaucoma"},{"key":"4462_CR18","first-page":"1032","volume":"97","author":"J Katz","year":"1990","unstructured":"Katz J, Sommer A. Screening for glaucomatous visual field loss. Eff patient Reliab Ophthalmol. 1990;97:1032\u20137.","journal-title":"Eff patient Reliab Ophthalmol"},{"key":"4462_CR19","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.2147\/OPTH.S14257","volume":"4","author":"E Chen","year":"2010","unstructured":"Chen E, Brown DM, Benz MS, Fish RH, Wong TP, Kim RY, et al. Spectral domain optical coherence tomography as an effective screening test for hydroxychloroquine retinopathy (the \u201cflying saucer\u201d sign). Clin Ophthalmol. 2010;4:1151\u20138.","journal-title":"Clin Ophthalmol"},{"key":"4462_CR20","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.ophtha.2013.12.002","volume":"121","author":"MF Marmor","year":"2014","unstructured":"Marmor MF, Melles RB. Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathy. Ophthalmology. 2014;121:1257\u201362.","journal-title":"Ophthalmology"},{"key":"4462_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ajo.2017.09.025","volume":"184","author":"SJ Ahn","year":"2017","unstructured":"Ahn SJ, Joung J, Lim HW, Lee BR. Optical coherence tomography protocols for screening of hydroxychloroquine retinopathy in Asian patients. Am J Ophthalmol. 2017;184:11\u20138.","journal-title":"Am J Ophthalmol"},{"key":"4462_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-19048-0","volume":"12","author":"KE Kim","year":"2022","unstructured":"Kim KE, Ryu SJ, Kim YH, Seo Y, Ahn SJ. Visual field examinations using different strategies in Asian patients taking hydroxychloroquine. Sci Rep. 2022;12:14778.","journal-title":"Sci Rep"},{"key":"4462_CR23","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1001\/archopht.118.9.1187","volume":"118","author":"JL Keltner","year":"2000","unstructured":"Keltner JL, Johnson CA, Quigg JM, Cello KE, Kass MA, MO Gordon. Confirmation of visual field abnormalities in the Ocular Hypertension Treatment Study. Ocular Hypertension Treatment Study Group. Arch Ophthalmol. 2000;118:1187\u201394.","journal-title":"Arch Ophthalmol"},{"key":"4462_CR24","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1016\/j.ophtha.2004.06.029","volume":"111","author":"J Kim","year":"2004","unstructured":"Kim J, Dally LG, Ederer F, Gaasterland DE, VanVeldhuisen PC, Blackwell B, et al. The advanced glaucoma intervention study (AGIS): 14. Distinguishing progression of glaucoma from visual field fluctuations. Ophthalmology. 2004;111:2109\u201316.","journal-title":"Ophthalmology"},{"key":"4462_CR25","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/S0161-6420(94)31133-X","volume":"101","author":"M Schulzer","year":"1994","unstructured":"Schulzer M. Errors in the diagnosis of visual field progression in normal-tension glaucoma. Ophthalmology. 1994;101:1589\u201394. discussion 95.","journal-title":"Ophthalmology"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04462-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04462-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04462-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T14:20:44Z","timestamp":1783434044000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04462-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["4462"],"URL":"https:\/\/doi.org\/10.1038\/s41433-026-04462-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6769459\/v1","asserted-by":"object"}]},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,5]]},"assertion":[{"value":"28 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}